Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
News: CYC Cyclopharm Posts FY Sales Revenue Of A$17.70 Million
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.050(3.13%) |
Mkt cap ! $172.2M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $13.25K | 8.366K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 539 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 2806 | 1 |
View Market Depth
| Last trade - 15.59pm 24/07/2024 (20 minute delay) ? |
| CYC (ASX) Chart |